These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7152484)

  • 1. Central dopaminergic excitatory and inhibitory systems in Nelson's syndrome.
    Nishida S; Matsuki M; Horino M; Endoh M; Kakita K; Tenku A; Oyama H
    Horm Metab Res; 1982 Dec; 14(12):681-2. PubMed ID: 7152484
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of changes in the plasma ACTH level on the prolactin response to metoclopramide or bromocriptine in normal subjects and patients with Nelson's syndrome.
    Nishida S; Matsuki M; Nagase Y; Horino M; Endoh M; Kakita K; Tenku A; Oyama H
    Horm Metab Res; 1984 Feb; 16(2):107-8. PubMed ID: 6323292
    [No Abstract]   [Full Text] [Related]  

  • 3. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome.
    Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M
    Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prolactin responses to metoclopramide in Cushing's syndrome and Nelson's syndrome.
    Kasperlik-Zaluska AA; Jeske W
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):351-5. PubMed ID: 6246703
    [No Abstract]   [Full Text] [Related]  

  • 5. [beta-endorphin secretion and its clinical significance in a patient with Nelson's syndrome (author's transl)].
    Oki S; Nakao K; Nakai Y; Imura H
    Nihon Naika Gakkai Zasshi; 1982 Apr; 71(4):458-66. PubMed ID: 6286812
    [No Abstract]   [Full Text] [Related]  

  • 6. Pituitary gonadotropic function in Nelson's syndrome.
    Kasperlik-Załuska A; Baranowska B; Jeske W; Rozbicka G
    Endokrynol Pol; 1985; 36(4):191-6. PubMed ID: 3938392
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
    Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is it possible to predict the development of Nelson's syndrome in Cushing's disease after bilateral adrenalectomy?].
    Horký K; Kanka J; Gregorová I; Tomsová Z; Dvoráková J
    Cas Lek Cesk; 1990 May; 129(21):645-9. PubMed ID: 2164450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nelson's syndrome after Cushing's disease in childhood: a continuing problem.
    Thomas CG; Smith AT; Benson M; Griffith J
    Surgery; 1984 Dec; 96(6):1067-77. PubMed ID: 6505960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dopaminergic receptors in the regulation of growth hormone secretion.
    Müller EE; Liuzzi A; Cocchi D; Panerai AE; Oppizzi G; Lacatelli V; Mantegazza P; Silvestrini F; Chiodini PG
    Adv Biochem Psychopharmacol; 1977; 16():127-38. PubMed ID: 142419
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dopaminergic regulation of hormone secretion of the pituitary gland and the adrenal gland].
    Jungmann E; Böttger B; Magnet W; Schulz F; Schwedes U; Althoff PH; Schöffling K
    Med Welt; 1983 Feb; 34(7):216-9. PubMed ID: 6835089
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of cyproheptadine, desmethylcyproheptadine, gamma-amino-butyric acid and sodium valproate on adrenocorticotrophin secretion by cultured pituitary tumour cells from three patients with Nelson's syndrome.
    Lamberts SW; Verleun T; Bons EG; Uitterlinden P; Oosterom R
    J Endocrinol; 1983 Mar; 96(3):401-6. PubMed ID: 6300275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heavy particle therapy: pituitary tumors.
    Linfoot JA; Nakagawa JS; Wiedemann E; Lyman J; Chong C; Garcia J; Lawrence JH
    Bull Los Angeles Neurol Soc; 1977; 42(3-4):175-89. PubMed ID: 227502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nelson's syndrome: case report and review of the literature.
    Ullrich I; Lizarralde G
    South Med J; 1977 Dec; 70(12):1444-6. PubMed ID: 202034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nelson's syndrome and spontaneous pituitary tumor infarction.
    Jordan RM; Cook DM; Kendall JW; Kerber CW
    Arch Intern Med; 1979 Mar; 139(3):340-2. PubMed ID: 426579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroendocrinology and schizophrenia research].
    Müller-Spahn F
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 64():1-96. PubMed ID: 1682802
    [No Abstract]   [Full Text] [Related]  

  • 18. [Increased secretion of prolactin after inhibition of dopaminergic receptors by metoclopramide in patients with cancer of the prostate].
    Baranowska B; Jeske W; Szymanowski J; Piechna K
    J Urol (Paris); 1983; 89(8):601-5. PubMed ID: 6203986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of macroprolactinoma with the new potent non-ergot D2-dopamine agonist quinagolide and effects on prolactin levels, pituitary function, an the renin-aldosterone system. Results of a clinical long-term study.
    Nickelsen T; Jungmann E; Althoff P; Schumm-Draeger PM; Usadel KH
    Arzneimittelforschung; 1993 Apr; 43(4):421-5. PubMed ID: 8098604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsurgical treatment of Nelson's syndrome.
    Xing B; Ren Z; Su C; Wang R; Yang Y; Hu Y
    Chin Med J (Engl); 2002 Aug; 115(8):1150-2. PubMed ID: 12215280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.